Immunic rises after $400M private placement, leadership transition
Source: SeekingAlpha
2026-02-13 08:46:37 ET
More on Immunic
- Seeking Alpha’s Quant Rating on Immunic
- Historical earnings data for Immunic
- Financial information for Immunic
Read the full article on Seeking Alpha
For further details see:
Immunic rises after $400M private placement, leadership transition
Immunic Inc.
NASDAQ: IMUX
IMUX Trading
-15.16% G/L:
$1.175 Last:
4,026,747 Volume:
$1.39 Open:
IMUX Latest News
March 10, 2026 06:30:00 am
Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium
February 26, 2026 06:30:00 am
Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update
February 17, 2026 04:05:00 pm
Immunic Announces Closing of Oversubscribed Private Placement Financing
IMUX Stock Data
$99,716,036
88,288,987
2.21%
24
N/A
Biotechnology & Life Sciences
Healthcare
US
New York
